mobile, connected, digital health... 10 envisioning dh paradigm an agile and learning regulatory...
TRANSCRIPT
Mobile, Connected, Digital Health Bakul Patel, MBA
Facilitating medical device innovation by advancing regulatory science, providing industry with predictable, consistent, transparent, and efficient regulatory pathways, and assuring consumer confidence in devices marketed in the U.S.
Enable “patient centered” public health as digitization touches every aspect of health care
Foster trust in innovative technologies as an enabler of a new healthcare paradigm
Partner with stakeholders to be "digital-future ready”
CDRH Objectives
Transforming the regulatory environment is becoming more challenging due to increasing complexities in the medical device innovation
Software is becoming more ubiquitous within medical devices; this results in an increased burden on regulatory agencies to conduct reviews in a timely fashion.
Medical Device Software Regulation What strategies can be employed to streamline review of medical device software without sacrificing regulatory oversight?
Changing Technology Landscape The rate of technology change presents significant challenges to the regulator. Innovation will continue to advance in the areas of microprocessors, material science, and manufacturing.
What approaches can be developed to strengthen the depth of expertise of the regulator when it comes to rapid changes in technology?
Real-World Evidence
Real-world data can provide powerful insight into the benefits and risks of medical devices, including how they are used by health care providers and patients
How does real-world evidence collection fit into the FDA’s strategic priority of creating a national evaluation system for medical devices?
Exploring the Issue
Risk based
Functionality focused
Platform independent
Promote innovation
Narrowly tailored
Promote patient
engagement
Protect patient safety
Smart Regulation
Don’t intend to enforce regulatory requirements
Appropriately oversee to assure patient safety while considering advances in technology and product life-cycle • Engaging stakeholders • Implementing policies • Raising staff expertise and
knowledge
Lower Risk Functionality
Higher Risk Functionality
Focusing on Higher Risk Functionality
6
Foundational Policies
RF Wireless -guidance
Mobile medical app (MMA)
FDASIA Health IT report
Premarket Cybersecurity
MDDS/image storage and communication
General wellness
Accessories Interoperability
Post-market cybersecurity
MMA update
7
Approach to Mobile Apps
No regulatory requirements
• Patient self-management apps • Tools to organize and track their health
information (not for treating or adjusting medications)
• Tools to access to health information document and communicate with health care providers
• Tools that automate simple health care providers tasks
Enforcement Discretion
Mobile apps not considered
“medical devices”
MMA
Lower risk mobile apps that meet “device”
Definition but not considered “MMA”
Mobile apps that meet “device” definition that are either intended • To be used as an accessory to
already regulated medical device, or
• To transform a mobile platform into a regulated medical device.
focus of oversight
8
Types of Medical Device Software
So$wareusedinthemanufacturingprocess
ofadevice
So$wareasadevice
So$wareinadevice
in as
u
9
On a Path Towards Global Convergence
2013 Foundational vocabulary
2014 – Risk framework based on impact to patients
2015 – QMS control èTranslating Software development practices to regulatory QMS
SaMD –Application of Clinical Evaluation
þ
þ
þ
White Oak, February 2016
www.fda.gov 10
Envisioning DH Paradigm
An Agile and learning regulatory paradigm that is:
An opportunity to work together to build this vision and prepare for a digital health future
Aligned with Product development timelines
Aligned with industry practices and real world
experience
Aligned with global regulators
DH TPLC
Clinical Trials
Regulatory Science
NEST
Progressive Approval, Safety and
Performance
Premarket-Postmarket
Balance AssuranceProgram
DH
DH Bakul
FDA Initiatives
FDAPre✔ RegulatoryDevelopmentKit
NEST
Digital Health and Mobile Apps email: [email protected]
Digital Health Contact
CDRH website: Digital health page http://www.fda.gov/MedicalDevices/DigitalHealth/default.htm
• What talent (skills, expertise, experience) should the FDA crowdsource?
• How should we differentiate digital health medical devices from traditional medical devices?
• What would you like to see part of a potential FDA pre-check program?
• What format / key components would be most useful for a regulatory development kit?
• How else could we achieve the same objectives?
We Need Your Input
Mariya Filipova [email protected]
Photo
Use the Exponential Medicine app to message or email directly your suggestions, questions comments to:
Join us for our workshop today at 1:45pm @ Carousel Room
Get in touch